| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83386 |
负载吡非尼酮的肺靶向纳米脂质体,GALA-PFD-Lip,多功能载药脂质体定制服务 |
195 |
axc |
2024-12-18 |
| 83387 |
PAMAM-PG-g-s-s-DOTA(Gd)+FA 纳米球状MRI造影剂 |
140 |
h |
2024-12-18 |
| 83388 |
DBCO-Val-Cit-PAB-MMAE，二苯并环辛炔-VAL-CIT-PAB-MMAE |
93 |
kx |
2024-12-18 |
| 83389 |
脂质体包裹噬菌体ABSZ6（LIP-ABSZ6），载药脂质体定制服务 |
466 |
axc |
2024-12-18 |
| 83390 |
DOTA-3G3-dimer DOTA-3G3-二聚体 |
97 |
h |
2024-12-18 |
| 83391 |
CAS: 1884578-27-1 Alloc-Val-Ala-PAB-PNP |
111 |
WYQ |
2024-12-18 |
| 83392 |
cas:646502-53-6 ，MC-Val-Cit-PAB-MMAE，VCMMAE 单甲基奥瑞他汀E |
122 |
kx |
2024-12-18 |
| 83393 |
布地奈德脂质体,Budesonide,liposomes,BUD-LNPs,靶向脂质体定制服务 |
135 |
axc |
2024-12-18 |
| 83394 |
DOTA-Lys-PEG4-[D-Phe6,Sta13]-BN(6-14)NH2(HZ219)DOTA缀合的GRPr拮抗剂 |
132 |
h |
2024-12-18 |
| 83395 |
[131I]SIB-PEG4-CHC 聚乙二醇化秋水仙素衍生物-定制 |
179 |
zyl |
2024-12-18 |
| 83396 |
PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针 |
108 |
h |
2024-12-18 |
| 83397 |
虾青素脂质体，提供荧光脂质体定制服务 |
139 |
axc |
2024-12-18 |
| 83398 |
PEG2-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2；peg2-RM26-科研定制 |
237 |
zyl |
2024-12-18 |
| 83399 |
DOTA-PEG(4)-[D-Phe(6) |
100 |
h |
2024-12-18 |
| 83400 |
Azide-PEG3-Val-Cit-PAB-MMAF，叠氮-三聚乙二醇-VAL-CIT-PAB-MMAF |
95 |
kx |
2024-12-18 |
| 83401 |
DOTA-3G(3)-dimer DOTA-3G(3)-二聚体 |
157 |
h |
2024-12-18 |
| 83402 |
HS-(CH2)11-triphenylimidazole；HS-(CH2)11-三苯基咪唑 |
153 |
zyl |
2024-12-18 |
| 83403 |
雷公藤甲素脂质体,1-Lips,脂质体纳米载体定制服务 |
106 |
axc |
2024-12-18 |
| 83404 |
DOTAGA-PEG(2)-RM26 DOTA修饰铃蟾肽衍生的GRPR拮抗剂PEG(2)-RM26 |
119 |
h |
2024-12-18 |
| 83405 |
cas:159857-79-1，Val-Cit-PAB，ADC定制 |
92 |
wyh |
2024-12-18 |
| 83406 |
2529982-76-9，Azido-PEG4-Val-Ala-PAB，叠氮-四聚乙二醇-VAL-ALA-PAB |
114 |
kx |
2024-12-18 |
| 83407 |
DOTA-PEG11-Tz DOTA-PEG11-四嗪 |
139 |
h |
2024-12-18 |
| 83408 |
阿霉素-卡铂脂质体,doxorubicin-carboplatin,liposome,DOX/CBP-Lip,多功能载药脂质体定制服务 |
138 |
axc |
2024-12-18 |
| 83409 |
HS(CH2)11OH烷基链定制 |
113 |
zyl |
2024-12-18 |
| 83410 |
NH(2)-PEG-DOTA-PEG-NH(2)-GQDs NH2-PEG-DOTA-PEG-NH2偶联羧基化石墨烯量子点 |
123 |
h |
2024-12-18 |
| 83411 |
Fmoc-Val-Cit-PAB-PNP（CAS:863971-53-3） |
100 |
WYQ |
2024-12-18 |
| 83412 |
Au23(S-c-C6H11)16 烷基链定制 |
133 |
zyl |
2024-12-18 |
| 83413 |
DOTA-PEG-OPSS-AuNP 邻吡啶基二硫化物-聚乙二醇-金属螯合剂DOTA修饰30纳米金纳米粒子(AuNP) |
111 |
h |
2024-12-18 |
| 83414 |
壳聚糖修饰芹菜素脂质体,CS-AP-L,载药脂质体定制服务 |
151 |
axc |
2024-12-18 |
| 83415 |
DBCO-PEG4-Val-Ala-PAB-PNP，二苯并环辛炔-四聚乙二醇-VAL-ALA-PAB-PNP |
92 |
kx |
2024-12-18 |
| 83416 |
cas:2412924-07-1，Py-MPB-amino-C3-PBD，ADC定制 |
94 |
wyh |
2024-12-18 |
| 83417 |
DOTA偶联胃泌素释放肽受体(GRP-R)配体 |
152 |
h |
2024-12-18 |
| 83418 |
HS(CH2)11(OCH2-CH2)6OCH2CO2H |
128 |
zyl |
2024-12-18 |
| 83419 |
芹菜素脂质体,Apigeninliposomes,AP-L,靶向脂质体定制服务 |
196 |
axc |
2024-12-18 |
| 83420 |
DOTA-diabody DOTA缀合的抗CEA双抗体 |
197 |
h |
2024-12-18 |
| 83421 |
cas:1810001-93-4，DBM-MMAF，ADC定制 |
151 |
wyh |
2024-12-18 |
| 83422 |
CH3(CH2)7COOH-CH3(CH2)7COOM (M =钠、钾、铷、铯)-定制 |
234 |
zyl |
2024-12-18 |
| 83423 |
cas:70396-18-8 ，Boc-Val-Ala-OH， ADC试剂 |
117 |
kx |
2024-12-18 |
| 83424 |
Boc-Val-Cit（CAS:870487-08-4），(S)-2-((S)-2-((叔丁氧基羰基)氨基)-3-甲基丁酰胺基)-5-脲基戊酸 |
121 |
WYQ |
2024-12-18 |
| 83425 |
213Bi-DOTA-PESIN 213Bi-DOTA-PEG(4)-铃蟾肽 |
183 |
h |
2024-12-18 |
| 83426 |
雷公藤甲素木蜡酸酯脂质体,triptolide,lignoceric,acid,ester,liposome,,TPL-LA-lip |
148 |
axc |
2024-12-18 |
| 83427 |
WR 2721 [H2N-(CH2)3-NH(CH2)2SPO3H2] |
151 |
zyl |
2024-12-18 |
| 83428 |
1228105-51-8，DM1-SMCC；SMCC-DM1，ADC定制 |
161 |
wyh |
2024-12-18 |
| 83429 |
Boc-Val-Cit-PAB（CAS:870487-09-5），分子式：C23H37N5O6 |
169 |
WYQ |
2024-12-18 |
| 83430 |
DOTA(1,4,7,10-四氮杂十二烷-N,N,N,N-四乙酸)之间的接头修饰环肽E-[c(RGDfK)]2 |
126 |
h |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询